DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology
Update: 2024-11-05
Description
In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel